These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 22970144

  • 1. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
    Maira-Litrán T, Bentancor LV, Bozkurt-Guzel C, O'Malley JM, Cywes-Bentley C, Pier GB.
    PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
    [Abstract] [Full Text] [Related]

  • 2. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
    Maira-Litrán T, Kropec A, Goldmann DA, Pier GB.
    Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353
    [Abstract] [Full Text] [Related]

  • 3. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine.
    Cerca N, Jefferson KK, Maira-Litrán T, Pier DB, Kelly-Quintos C, Goldmann DA, Azeredo J, Pier GB.
    Infect Immun; 2007 Jul; 75(7):3406-13. PubMed ID: 17470540
    [Abstract] [Full Text] [Related]

  • 4. The role of epitope specificity in the human opsonic antibody response to the staphylococcal surface polysaccharide poly N-acetyl glucosamine.
    Kelly-Quintos C, Kropec A, Briggs S, Ordonez CL, Goldmann DA, Pier GB.
    J Infect Dis; 2005 Dec 01; 192(11):2012-9. PubMed ID: 16267775
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
    Tkaczyk C, Hamilton MM, Sadowska A, Shi Y, Chang CS, Chowdhury P, Buonapane R, Xiao X, Warrener P, Mediavilla J, Kreiswirth B, Suzich J, Stover CK, Sellman BR.
    mBio; 2016 Jun 28; 7(3):. PubMed ID: 27353753
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.
    Scully IL, Timofeyeva Y, Keeney D, Matsuka YV, Severina E, McNeil LK, Nanra J, Hu G, Liberator PA, Jansen KU, Anderson AS.
    Vaccine; 2015 Oct 05; 33(41):5452-5457. PubMed ID: 26319743
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Immunological comparison of Efb and ClfA of Staphylococcus aureus isolated from bovine].
    Liu Y, Sul Y, Zhang B, Su L, Jiang H.
    Sheng Wu Gong Cheng Xue Bao; 2015 Sep 05; 31(9):1335-43. PubMed ID: 26955711
    [Abstract] [Full Text] [Related]

  • 12. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.
    Skurnik D, Kropec A, Roux D, Theilacker C, Huebner J, Pier GB.
    Clin Infect Dis; 2012 Nov 05; 55(9):1188-97. PubMed ID: 22806596
    [Abstract] [Full Text] [Related]

  • 13. A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure.
    Hawkins J, Kodali S, Matsuka YV, McNeil LK, Mininni T, Scully IL, Vernachio JH, Severina E, Girgenti D, Jansen KU, Anderson AS, Donald RG.
    Clin Vaccine Immunol; 2012 Oct 05; 19(10):1641-50. PubMed ID: 22896688
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.
    Begier E, Seiden DJ, Patton M, Zito E, Severs J, Cooper D, Eiden J, Gruber WC, Jansen KU, Anderson AS, Gurtman A.
    Vaccine; 2017 Feb 22; 35(8):1132-1139. PubMed ID: 28143674
    [Abstract] [Full Text] [Related]

  • 16. Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.
    Pozzi C, Wilk K, Lee JC, Gening M, Nifantiev N, Pier GB.
    PLoS One; 2012 Feb 22; 7(10):e46648. PubMed ID: 23077517
    [Abstract] [Full Text] [Related]

  • 17. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
    Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T.
    J Infect Dis; 2001 Dec 15; 184(12):1572-80. PubMed ID: 11740733
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
    Tkaczyk C, Kasturirangan S, Minola A, Jones-Nelson O, Gunter V, Shi YY, Rosenthal K, Aleti V, Semenova E, Warrener P, Tabor D, Stover CK, Corti D, Rainey G, Sellman BR.
    Antimicrob Agents Chemother; 2017 Aug 15; 61(8):. PubMed ID: 28584141
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.